# The Complicated Relationship Between Big Pharma and Cannabis > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/the-complicated-relationship-between-big-pharma-and-cannabis/ > **Published:** 2026-09-06T07:24:21-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T10:45:32-04:00 > **Clinical Summary:** Explore the evolving relationship between Big Pharma and cannabis research, its implications for patient care, and what clinicians should monitor. --- ✦ New CED Clinical Relevance #57 Clinical Context Background information relevant to the evolving cannabis medicine landscape. SleepPainAnxietyNeurologyPolicyResearchSafety Why This Matters This article matters significantly for clinicians and their patients as it highlights the potential integration of cannabinoids from cannabis into mainstream pharmaceuticals. Understanding this relationship can help clinicians stay informed about emerging treatment options, potentially improving patient care. Furthermore, awareness of Big Pharma’s interest in cannabis may influence clinical decision-making regarding cannabis-based therapies and their role in managing various medical conditions. Clinical Summary In the expanding realm of cannabis research, pharmaceutical companies are showing growing interest in cannabinoids as potential bases for novel medications. This complex relationship between Big Pharma and cannabis could lead to advancements in medication development, potentially impacting current clinical practices and patient care. Clinicians should stay informed about these developments to ensure they can provide the most up-to-date treatment options for their patients. Dr. Caplan’s Take “As a seasoned family physician specializing in cannabis medicine, I’ve witnessed the burgeoning interest of Big Pharma in cannabinoids. While this relationship holds promise for novel pharmaceuticals, it’s crucial to acknowledge that the current evidence base is still evolving. As we navigate this complex landscape, careful consideration and rigorous scientific scrutiny will be essential to ensure patient safety and efficacy.” Clinical Perspective 💊🌿 In the evolving landscape of healthcare, the complex relationship between Big Pharma and cannabis warrants careful consideration by clinicians. As research uncovers potential therapeutic benefits of cannabinoids, pharmaceutical companies may seek to leverage these compounds for novel drug development. However, it’s crucial to acknowledge the intricate web of regulatory, legal, and ethical complexities that surround cannabis use. Confounders such as varying potency levels, inconsistent product quality, and potential interactions with other medications necessitate vigilance in patient care. A practical clinical implication is the need for healthcare providers to stay informed about cannabis research and its implications, fostering open dialogue with patients about their cannabis use and monitoring for any adverse effects or interactions with prescribed medications. 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/forum/sleep/) Have thoughts on this? Share it: [X Share on X](https://twitter.com/intent/tweet?text=Just%20read%20this%20on%20CEDclinic.com%3A%20The%20Complicated%20Relationship%20Between%20Big%20Pharma%20and%20Cannabis%20%40drcaplan&url=https%3A%2F%2Fcedclinic.com%2F%3Fp%3D90685)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A%2F%2Fcedclinic.com%2F%3Fp%3D90685)[🦅 Share on BlueSky](https://bsky.app/intent/compose?text=Just%20read%20this%3A%20The%20Complicated%20Relationship%20Between%20Big%20Pharma%20and%20Cannabis%20via%20%40drcaplan.bsky.social%20https%3A%2F%2Fcedclinic.com%2F%3Fp%3D90685)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan)[📝 Read more on Substack](https://doctorapprovedcannabis.substack.com/)[🔔 Subscribe via RSS](https://cedclinic.com/feed/) Related Articles - [NY Times Response: Teens and Strong Cannabis](https://cedclinic.com/high-potency-cannabis-risks/) - [Cannabis Blood Sugar Levels: What the Evidence Shows for Wellness and Balance](https://cedclinic.com/cannabis-blood-sugar-levels-what-the-evidence-shows-for-wellness-and-balance/) - [Understanding Modern Cannabis Extraction Methods and Product Quality](https://cedclinic.com/understanding-modern-cannabis-extraction-methods-and-product-quality/) 📰 Source: [https://thefreshtoast.com/news/the-complicated-relationship-between-big-pharma-and-cannabis/](https://thefreshtoast.com/news/the-complicated-relationship-between-big-pharma-and-cannabis/) Further Reading CED Clinic Blog[Why Cannabis Works](https://cedclinic.com/why-cannabis-works/) Evidence Watch[Cannabis and Heart Health](https://cedclinic.com/cannabis-cardiovascular-health-study/) CED Clinic Blog[Cannabis for Sleep](https://cedclinic.com/cannabis-for-sleep/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Former CMO Canna Care Docs (250,000+ patients supervised), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).